Back to News
Market Impact: 0.78

Stock Market Today: Indexes Pull Back to Begin Week as Tech Shares Fall; Treasury Yields Remain Elevated

NVDADNEEUNHBRK.BREGNTGTHDMSBACDALMGOOGLAAPLAMZNMAVBA
Interest Rates & YieldsEnergy Markets & PricesGeopolitics & WarCorporate EarningsFutures & OptionsMarket Technicals & FlowsHealthcare & BiotechConsumer Demand & Retail
Stock Market Today: Indexes Pull Back to Begin Week as Tech Shares Fall; Treasury Yields Remain Elevated

Major U.S. indexes fell to start a heavy earnings week, with the Nasdaq down 0.7% and the S&P 500 down 0.3% as the 10-year Treasury yield held near 4.60%, its highest level in a year. Oil prices extended gains, with WTI up 1.4% to nearly $107 a barrel and Brent up 1.6% to $111, amid heightened Iran-related geopolitical risk. Individual movers were mixed: Nvidia was lower ahead of Wednesday earnings, Dominion Energy jumped 10% on its deal with NextEra, and Regeneron tumbled 10% after a late-stage melanoma trial miss.

Analysis

The market is transitioning from an earnings-driven tape to a macro liquidity tape. When rates, oil, and geopolitics all tighten simultaneously, the first-order hit is multiples, but the second-order hit is dispersion: balance-sheet quality and pricing power matter more than narrative growth. That argues for fading crowded duration-sensitive winners and leaning into businesses with regulated or contracted cash flows that can reprice faster than input costs. Energy is the obvious transmission channel, but the more interesting knock-on effect is on consumers and rate-sensitive sectors. Higher gasoline and mortgage rates hit the same marginal household, which means discretionary spend likely deteriorates with a lag into late Q2/Q3 even if headline employment remains stable. That makes home improvement and discretionary retail more vulnerable than the market is pricing, especially where management teams are leaning on traffic recovery narratives just as financing costs and basket pressure re-accelerate. In healthcare, the Regeneron read-through is less about one melanoma program and more about pipeline de-risking being discounted too cheaply across mid-cap biotech after a strong tape. This is the kind of event that can reset probability-weighted valuation models quickly because failure in a late-stage combo study often compresses the entire platform multiple, not just the asset. By contrast, Berkshire’s portfolio changes signal a more defensive capital-allocation regime: buyers of cash-generative, non-consensus names can outperform in a higher-for-longer world if they are insulated from tariff, fuel, or rate shock. The contrarian point: the market may be overestimating how much further yields can rise without triggering a growth scare that eventually forces a rotation back into defensives and long-duration quality. If Nvidia delivers a beat but guides only modestly above the new, higher hurdle, the stock can still sell off on good news because positioning is the real risk. That sets up a post-earnings volatility opportunity rather than a clean directional bet.